Copyright
©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Figure 1 Types of malignancies in the study population.
Figure 2 Pie chart depicting the distribution of malignancy among hematology and solid organ malignancy.
Figure 3 Prevalence of hepatitis B surface antigen in oncology and hemato-oncology patients.
HBsAg: Hepatitis B surface antigen.
Figure 4 Age distribution of the chronic hepatitis subgroup.
- Citation: Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104
- URL: https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i1.89104